Industry News

      Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors

      SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Bctn--Circle Pharma, a leader in macrocycle drug discovery and development, announced the submission of its first...

      N-Power Medicine Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials

      REDWOOD CITY, Calif.--(BUSINESS WIRE)--N-Power Medicine emerges with Series B funding to bolster access to innovative oncology clinical trials...

      N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials

      REDWOOD CITY, Calif.--(BUSINESS WIRE)--N-Power Medicine collaborates with Merck to expand oncologist and patient access to clinical trials...

      Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic...

      RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced...

      Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs

      SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on...

      Parkinson’s Disease: A Digital Biomarker Platform for Differentiated Diagnosis

      STRASBOURG, France--(BUSINESS WIRE)-- #PrecisionNeurology--BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals,...

      Recent Articles